Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy
Circulation · 17.11.2026 · 154 (20) · 2031-2037
DOI: 10.1161/circulationaha.126.080166 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 17.11.2026. Verfasst von Xiang Wei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Septal Myectomy, Heart Septum. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben.
Abstract (Originalsprache)
Hypertrophic cardiomyopathy (HCM) is a prevalent heterogenous genetic cardiac disorder. In the cardiac myosin inhibitor era, the guideline-directed management of HCM remains an emerging frontier worldwide. Septal myectomy has been the gold standard treatment option for obstructive HCM over the past 60 years. However, the complexity of this procedure and required expertise (and lack of qualified training) have limited its success and availability beyond high-volume HCM centers. Transapical beating-heart septal myectomy (TA-BSM), a newly developed innovative technique, simplifies conventional septal myectomy by eliminating the need for sternotomy, cardiopulmonary bypass, and aortotomy. Most important, the inclusion of real-time intraoperative echocardiographic guidance and evaluation makes TA-BSM safer, more precise, cost-effective, and reproducible. The apparent advantages of TA-BSM, including substantial reductions in surgical trauma and operating times and much faster postoperative recovery in patients with obstructive HCM, are encouraging. TA-BSM is particularly feasible in patients with long-segment obstruction, or small aortic valve annulus, or in those who had undergone previous cardiac operations. The frequent resolution of systolic anterior motion and associated mitral regurgitation after TA-BSM, without concomitant mitral valve intervention, highlights the central role of intraoperative echocardiography and close surgeon-echocardiographer collaboration in achieving optimal procedural outcomes. Further multicenter evaluation of TA-BSM will help define its role among septal reduction strategies for patients with obstructive HCM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Institute of Cardiovascular Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Zitieren
APA
Wei, X., Fang, J., & Wan, S. (2026). Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Circulation, 154(20), 2031-2037. https://doi.org/10.1161/circulationaha.126.080166
Vancouver
Wei X, Fang J, Wan S. Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy. Circulation. 2026;154(20):2031-2037. doi:10.1161/circulationaha.126.080166
BibTeX
@article{Wei2026,
author = {Wei, Xiang and Fang, Jing and Wan, Song},
title = {Transapical Beating-Heart Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy},
journal = {Circulation},
year = {2026},
volume = {154},
number = {20},
pages = {2031--2037},
doi = {10.1161/circulationaha.126.080166}
}
EUVIMED